Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Trude H. Ågesen"'
Autor:
Marine Jeanmougin, Annette B. Håvik, Lina Cekaite, Petter Brandal, Anita Sveen, Torstein R. Meling, Trude H. Ågesen, David Scheie, Sverre Heim, Ragnhild A. Lothe, Guro E. Lind
Publikováno v:
Molecular Oncology, Vol 14, Iss 5, Pp 1016-1027 (2020)
Glioblastoma (GBM), the most aggressive form of brain cancer, is characterized by a high level of molecular heterogeneity, and infiltration by various immune and stromal cell populations. Important advances have been made in deciphering the microenvi
Externí odkaz:
https://doaj.org/article/50f176e97628490093af05af0a6840dd
Autor:
Lina Cekaite, Juha K. Rantala, Jarle Bruun, Marianne Guriby, Trude H. Ågesen, Stine A. Danielsen, Guro E. Lind, Arild Nesbakken, Olli Kallioniemi, Ragnhild A. Lothe, Rolf I. Skotheim
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 14, Iss 9, Pp 868-879 (2012)
Several microRNAs (miRNAs) are known to be deregulated in colon cancer, but the mechanisms behind their potential involvement on proliferation and tumor cell survival are unclear. The present study aimed to identify miRNAs with functional implication
Externí odkaz:
https://doaj.org/article/fec7c093a2f84e6cafaa0c5f14d3aa5b
Autor:
Ragnhild A. Lothe, Rolf I. Skotheim, Knut Liestøl, Torleiv O. Rognum, Gunn Iren Meling, Arild Nesbakken, Trude H. Ågesen, Anita Sveen
Purpose: Improved prognostic stratification of patients with stage II and III colorectal cancer is warranted for postoperative clinical decision making. This study was conducted to develop a clinically feasible and robust prognostic classifier for th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13f159cd66c2aba5c21a03bb80169be7
https://doi.org/10.1158/1078-0432.c.6521189.v1
https://doi.org/10.1158/1078-0432.c.6521189.v1
Autor:
Ragnhild A. Lothe, Rolf I. Skotheim, Knut Liestøl, Torleiv O. Rognum, Gunn Iren Meling, Arild Nesbakken, Trude H. Ågesen, Anita Sveen
PDF file - 292K, The Supplementary Material contains Supplementary Methods, Supplementary Tables S1 and S2, and Supplementary Figures S1-S4 Table S1. Genes in the prognostic expression signature Table S2. Cox proportional hazards analyses for patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::004deac998fb9e3eaa9f4d23c3282552
https://doi.org/10.1158/1078-0432.22447733
https://doi.org/10.1158/1078-0432.22447733
Autor:
Sverre Heim, Torstein R. Meling, Anita Sveen, Lina Cekaite, Petter Brandal, Marine Jeanmougin, Ragnhild A. Lothe, David Scheie, Annette Bentsen Håvik, Guro Elisabeth Lind, Trude H. Ågesen
Publikováno v:
Molecular Oncology
Jeanmougin, M, Håvik, A B, Cekaite, L, Brandal, P, Sveen, A, Meling, T R, Ågesen, T H, Scheie, D, Heim, S, Lothe, R A & Lind, G E 2020, ' Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment ', Molecular Oncology, vol. 14, no. 5, pp. 1016-1027 . https://doi.org/10.1002/1878-0261.12668
Molecular Oncology, Vol 14, Iss 5, Pp 1016-1027 (2020)
Molecular Oncology, Vol. 14, No 5 (2020) pp. 1016-1027
Jeanmougin, M, Håvik, A B, Cekaite, L, Brandal, P, Sveen, A, Meling, T R, Ågesen, T H, Scheie, D, Heim, S, Lothe, R A & Lind, G E 2020, ' Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment ', Molecular Oncology, vol. 14, no. 5, pp. 1016-1027 . https://doi.org/10.1002/1878-0261.12668
Molecular Oncology, Vol 14, Iss 5, Pp 1016-1027 (2020)
Molecular Oncology, Vol. 14, No 5 (2020) pp. 1016-1027
Glioblastoma (GBM), the most aggressive form of brain cancer, is characterized by a high level of molecular heterogeneity, and infiltration by various immune and stromal cell populations. Important advances have been made in deciphering the microenvi
Autor:
Stine A Danielsen, Lina Cekaite, Trude H Ågesen, Anita Sveen, Arild Nesbakken, Espen Thiis-Evensen, Rolf I Skotheim, Guro E Lind, Ragnhild A Lothe
Publikováno v:
PLoS ONE, Vol 6, Iss 9, p e24419 (2011)
Colorectal cancer (CRC) is one of the most common cancer types in developed countries. To identify molecular networks and biological processes that are deregulated in CRC compared to normal colonic mucosa, we applied Gene Set Enrichment Analysis to t
Externí odkaz:
https://doaj.org/article/b52b8ddb18ba473eb13bdcb6209dac78
Autor:
Marianne Berg, Stine A Danielsen, Terje Ahlquist, Marianne A Merok, Trude H Ågesen, Morten H Vatn, Tom Mala, Ole H Sjo, Arne Bakka, Ingvild Moberg, Torunn Fetveit, Øystein Mathisen, Anders Husby, Oddvar Sandvik, Arild Nesbakken, Espen Thiis-Evensen, Ragnhild A Lothe
Publikováno v:
PLoS ONE, Vol 5, Iss 11, p e13978 (2010)
The incidence of colorectal cancer (CRC) increases with age and early onset indicates an increased likelihood for genetic predisposition for this disease. The somatic genetics of tumor development in relation to patient age remains mostly unknown. We
Externí odkaz:
https://doaj.org/article/90f894b92cb24cd0a160196f6e0ed3ec
Autor:
Kirsten Sundby Hall, Ben Davidson, Matthias Kolberg, Maren Høland, Nils Mandahl, Fredrik Mertens, Sigbjørn Smeland, Rolf Inge Skotheim, Guro Elisabeth Lind, Trude H. Ågesen, Ragnhild A. Lothe
Publikováno v:
Molecular Oncology
No consensus treatment regime exists beyond surgery for malignant peripheral nerve sheath tumours (MPNST), and the purpose of the present study was to find new approaches to stratify patients with good and poor prognosis and to better guide therapeut
Autor:
Ragnhild A. Lothe, Kjell Magne Tveit, Trude H. Ågesen, Arild Nesbakken, Marianne Grønlie Guren, Anita Sveen, Rolf Inge Skotheim
Publikováno v:
Clinical Cancer Research. 19:6669-6677
Purpose: According to current recommendations for adjuvant treatment, patients with colon cancer stage II are not routinely offered chemotherapy, unless considered to have a high risk of relapse based on specific clinicopathological parameters. Follo
Autor:
Helge R. Brekke, Fredrik Mertens, Maren Høland, Kirsten Sundby Hall, Ragnhild A. Lothe, Trude H. Ågesen, Matthias Kolberg, Sigbjørn Smeland, Piero Picci, Knut Liestøl
Publikováno v:
Neuro-Oncology
There are conflicting reports as to whether malignant peripheral nerve sheath tumor (MPNST) patients with neurofibromatosis type 1 (NF1) have worse prognosis than non-NF1 MPNST patients. Large clinical studies to address this problem are lacking due